Skip to main content
Back to Andreessen Horowitz

Andreessen Horowitz's Life Science Portfolio

Browse 14 Life Science companies funded by Andreessen Horowitz. See funding amounts, founder contacts, and investment details.

Life Science Companies
14
Total Funding in Life Science
$2.0B

Life Science Portfolio Companies (14)

Export
BiotechnologyLife ScienceTherapeutics

Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives.

San Francisco, United States
July 2022
$65.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

Alameda, United States
July 2026
$7.5M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceOncologyPharmaceutical

Erasca is a developer of oncology drugs intended to provide precision oncology options.

San Diego, United States
July 2026
$632.5M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceOncologyTherapeutics

Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.

South San Francisco, United States
May 2026
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

Ultima Genomics is a developer of a low-cost sequencing platform.

Newark, United States
May 2022
$600.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

EdTechEducationE-LearningLife ScienceSimulationVirtual Reality

Labster is an e-learning company that offers virtual laboratory simulations based on mathematical algorithms.

Copenhagen, Denmark
April 2022
$47.0M
Series C

Founder Contacts

41,000+ verified contacts

Alternative MedicineBiotechnologyLife ScienceTherapeutics

Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.

Cambridge, United States
April 2023
$270.0M
Series A

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyGeneticsHealth CareLife Science

Deepcell is a life science company specializing in AI-powered single-cell classification and isolation for basic and translational research.

Menlo Park, United States
April 2025
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyLife Science

Octant Bio is a developer of synthetic technology used to improve health and treat disease.

Los Angeles, United States
April 2022
$80.0M
Series B

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife ScienceMarket Research

Phylo provides an integrated workspace with AI-assisted tools to support planning, execution, and review of biological research.

South San Francisco, United States
February 2026
$13.5M
Seed

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.

Boston, United States
September 2024
$65.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceOncologyProduct Research

Idrx is a clinical-stage biopharmaceutical that develops oncology-based precision therapies to treat cancer.

Cambridge, United States
August 2024
$120.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife Science

Elegen is a biotechnology company that develops microfluidic technology.

San Carlos, United States
May 2024
$35.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceMedical

Inceptive designs RNA molecules using large-scale deep learning in a tight loop with high-throughput experiments.

Palo Alto, United States
September 2023
$100.0M
Series A

Founder Contacts

41,000+ verified contacts

Explore Andreessen Horowitz's Full Portfolio

View all companies funded by Andreessen Horowitz across every industry and funding stage.

View Full Andreessen Horowitz Portfolio